Collaboration - September 14, 2024
New report: Recommendations to strengthen Nordic co-operation
In the report Nordic added value in inter-ministerial Nordic co-operation, funded through NordForsk by the Nordic Council of Ministers, the researchers present six recommendations to optimize the use of the concept of ‘Nordic added value’ across Nordic institutions.
Collaboration - September 3, 2024
Theranostics Trial Center receives over SEK 15 million from Vinnova
The Theranostics Trial Center (TTC) at Karolinska University Hospital has been awarded financing from Vinnova to run a new project in precision medicine. By combining image-guided diagnostics and therapy with radioactively labeled target-seeking drugs, the project aims to revolutionize cancer treatment in Sweden. “This grant is a big step for our research and a clear […]
Collaboration - August 30, 2024
Gothenburg & AstraZeneca collaborate for a stronger life science sector
Business Region Göteborg and AstraZeneca have entered a strategic collaboration with the aim to further strengthen the entire life science sector and create jobs and growth in the region. “In order to strengthen the sector and competitiveness in the Gothenburg region, closer strategic cooperation is needed in the life science area, and AstraZeneca is obviously […]
Agreement - August 30, 2024
Rokote Laboratories signs an agreement with 3PBIOVIAN
Rokote Laboratories Finland has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2. 3PBIOVIAN will provide Rokote Laboratories with Drug Substance and Drug Product to bring the intranasal FINCoVac 2.1 vaccine into Phase I clinical studies. The […]
Collaboration - August 27, 2024
The next expansion phase of Oslo Cancer Cluster Innovation Park
An agreement has been signed between Oslo City Council and Oslo Science Hub to sell the lots necessary for the planned building that will transform the Oslo Montebello area into an international power centre for cancer research. “Our vision is to create a vital and inclusive environment where researchers, entrepreneurs and companies at the Radium […]
Agreement - August 22, 2024
Oblique in agreement with Eli Lilly and Company
The Swedish biotech company has entered into a research collaboration agreement with Eli Lilly and Company to apply its AbiProt technology to generate antibodies against a well-validated target protein. This partnership aims to accelerate research and development of innovative treatments and, if successful, will generate milestone payments and royalty income, states the company. Under the […]
